Case number 1:21-cv-01062
Allergan USA, Inc. et al v. Aurobindo Pharma Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Feb 24, 2022 | 19 | Amended Order (4) |
| Feb 24, 2022 | 19 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): 11,007,179 B2; 11,090,291 B2. (Attachments: # (1) Amended Order)(nms) |
| Feb 10, 2022 | 18 | Order (4) |
| Feb 10, 2022 | 18 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,007,179 B2; 11,090,291 B2. (Attachments: # (1) Order)(nms) |
| Feb 9, 2022 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per entry of D.I. 330 in Lead Civil Action 19-1727-RGA. (nms) |
| Nov 18, 2021 | 17 | Notice of Appearance (1) Docket Text: NOTICE of Appearance by R. Touhey Myer on behalf of Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. (Myer, R.) |
| Aug 30, 2021 | 16 | Order (7) Docket Text: SO ORDERED Granting (D.I. 15 in 21-cv-1062-RGA; D.I. 12 in 21-cv-1064-RGA; D.I. 12 in 21-cv-1061-RGA; D.I. 225 in 19-cv-1727-RGA; D.I. 11 in 21-cv-1065-RGA; D.I. 13 in 21-cv-1066-RGA; D.I. 12 in 21-cv-1063-RGA) Stipulation and Proposed Order to Consolidate and Extend Time (*Reset Deadlines/Hearings: Joint Claim Construction Brief due by 12/3/2021, Pretrial Order due by 10/11/2022, Status letter due by 7/6/2022, A Bench Trial is set to start 11/7/2022, at 8:30 AM in Courtroom 6A) (see Order for further details). Signed by Judge Richard G. Andrews on 8/30/2021. Associated Cases: 1:19-cv-01727-RGA et al.(nms) |
| Aug 27, 2021 | 15 | Letter to Judge Andrews (2) |
| Aug 27, 2021 | 15 | Main Document (7) Docket Text: STIPULATION and [Proposed] Order to Consolidate and Extend Time, by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Attachments: # (1) Letter)(Tigan, Jeremy) Modified on 8/30/2021 (nms). |
| Aug 17, 2021 | 13 | Amended Complaint* (1) |
| Aug 17, 2021 | 14 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,007,179 B2; 11,090,291 B2. (Tigan, Jeremy) Modified on 8/18/2021 (nms). |
| Aug 17, 2021 | 13 | Exhibits A-B (50) |
| Aug 17, 2021 | 13 | Main Document (10) Docket Text: FIRST Amended Complaint against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. - filed by Allergan USA, Inc., Allergan Holdings Unlimited Company, Eden Biodesign, LLC. (Attachments: # (1) Exhibits A-B)(Tigan, Jeremy) Modified on 8/18/2021 (nms). |
| Aug 11, 2021 | 12 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. (Tigan, Jeremy) |
| Aug 5, 2021 | 10 | Answer to Complaint (10) Docket Text: ANSWER to [1] Complaint, by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc..(Dorsney, Kenneth) |
| Aug 5, 2021 | 11 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Limited, Inc. for Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc.. (Dorsney, Kenneth) Modified on 8/6/2021 (nms). |
| Jul 29, 2021 | 9 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Allergan USA, Inc., Allergan Holdings Unlimited Company, Eden Biodesign, LLC. Aurobindo Pharma USA, Inc. served on 7/29/2021, answer due 8/19/2021. (Tigan, Jeremy) |
| Jul 29, 2021 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Allergan USA, Inc., Allergan Holdings Unlimited Company, Eden Biodesign, LLC. Aurobindo Pharma Ltd. served on 7/29/2021, answer due 8/19/2021. (Tigan, Jeremy) |
| Jul 29, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:21-cv-01061-RGA through 1:21-cv-01066-RGA (rjb) |
| Jul 28, 2021 | 7 | Letter (2) Docket Text: Letter to John A. Cerino, Clerk of the Court from Jeremy A. Tigan regarding Notice of Related Cases. (Tigan, Jeremy) |
| Jul 28, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:21-cv-01061-LPS through 1:21-cv-01066-LPS (rjb) |
| Jul 26, 2021 | 6 | Summons Issued (2) |
| Jul 26, 2021 | 6 | Main Document (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma Ltd. on 7/26/2021; Aurobindo Pharma USA, Inc. on 7/26/2021. (Attachments: # (1) Summons Issued)(mal) |
| Jul 23, 2021 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AbbVie Inc. for Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC. filed by Allergan Holdings Unlimited Company, Allergan USA, Inc., Eden Biodesign, LLC.. (mal) |
| Jul 23, 2021 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,007,179,B2. (mal) |
| Jul 23, 2021 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: n/a. Date of Expiration of Patent: 03/14/2033. Thirty-Month Stay Deadline: n/a (mal) |
| Jul 23, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Jul 23, 2021 | 1 | Civil Cover Sheet (2) |
| Jul 23, 2021 | 1 | Exhibit A (26) |
| Jul 23, 2021 | 1 | Complaint* (1) |
| Jul 23, 2021 | 1 | Main Document (8) Docket Text: COMPLAINT filed against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3664621.) - filed by Allergan USA, Inc., Allergan Holdings Unlimited Company, Eden Biodesign, LLC.. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(mal) |
